Clotrimazole 1%
- Product NDC
- 69771-032
- 11-digit product format
- 697710032
- Labeler code
- 69771
- Product ID
- 69771-032_334f174d-fe88-517d-e063-6394a90a8d4d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Clotrimazole
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- GERI-GENTLE CORPORATION
- Application
- M005
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-08-17
- Substance
- CLOTRIMAZOLE
- Active strength
- 10 mg/g
- Pharmacologic classes
- Azole Antifungal [EPC], Azoles [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 69771-032-23 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 69771-032-23 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 69771-032-23 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 69771-032-23 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 69771-032-23 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 69771-032-23 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 69771-032-23 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 69771-032-23 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 69771-032-23 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 69771-032-23 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 69771-032-23 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 69771-032-23 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 69771-032-23 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clotrimazole 1%
- Brand name suffix
- Athletes Foot
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CLOTRIMAZOLE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| G07GZ97H65 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 309367 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e673748f-d00b-4ce8-e053-2995a90a9220 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b64d2752-34ef-378a-1f4f-8bff32b0d1ae | Product name | 4 | 20250626 |
| cb7783e0-feaa-7e56-fb3b-d43b6efa77c9 | Product name | 2 | 20250121 |
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| f5395dd2-4395-d8c6-3477-8c2d4a2f951c | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69771-032-23 | 2025-04-21 | C162847 | 48780-1 | 1030e365-3833-111a-e063-dadaa90a10e2 | GG Clotrimazole USP, 1% |
| 69771-032-23 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3833-111a-e063-dadaa90a10e2 | GG Clotrimazole USP, 1% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69771-032-23 | Clotrimazole 1%Athletes Foot | 113 g in 1 TUBE | CREAM | 113 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole | CLOTRIMAZOLE | AvPAK | 3ca3b475-7b69-442a-e063-6294a90a7b3f | 2025-08-18 | Warnings | M005 |
| Formula 3 | TOLNAFTATE | The Tetra Corporation | 0895274b-a09d-4264-a43f-852e44eb3163 | 2025-08-18 | Warnings | M005 |
| Formula 7 - The Solution | TOLNAFTATE | The Tetra Corporation | 18619649-7f79-4b6e-8b7c-69d70365d557 | 2025-08-18 | Warnings | M005 |
| GlyCylic | SALICYLIC ACID | The Tetra Corporation | 501d3ba9-ba42-4c1c-983b-492adaee039d | 2025-08-18 | Warnings | M005 |
| SupreH Ringworm Treatment Balm | SUPREH RINGWORM TREATMENT BALM | Shenzhen Xinxin Yunhai Technology Co., Ltd. | 3c77222b-d92e-84b0-e063-6294a90aadd7 | 2025-08-16 | Warnings | M005 |
| OetMoe Antifungal Solution | OETMOE ANTIFUNGAL SOLUTION | Shenzhen Earth Surface Trading Co., Ltd. | 3c26d917-4186-6f02-e063-6394a90a99f6 | 2025-08-12 | Warnings | M005 |
| Cureforte Anti Fungal Foot Care | ANTI FUNGAL FOOT CARE DROPS | STEEL CITY HEALTH PRIVATE LIMITED | 39f762a6-9d0c-8ded-e063-6394a90a3659 | 2025-08-11 | Warnings | M005 |
| Derman Antifungal Powder Tolnaftate | TOLNAFTATE | Taisho Pharmaceutical California Inc. | 3a854765-740c-4719-8abf-4b3f932cdee0 | 2025-08-07 | Warnings | M005 |
| Derman antifungal cream | TOLNAFTATE | Taisho Pharmaceutical California Inc. | 15d9b3c9-01af-4083-a1bc-014505d8798d | 2025-08-07 | Warnings | M005 |
| Maximum Strength Antifungal Liquid | TOLNAFTATE | Hudson Health LLC | 24b22794-f9f8-6f32-e063-6394a90aec98 | 2025-08-07 | Warnings | M005 |
| Toe Area Treatment | TOLNAFTATE | CVS | 17681cc8-fbb1-a0cf-e063-6294a90add18 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Family Dollar Services, Inc | 178e7b3f-949f-3f51-e063-6294a90a9395 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | LEADER/Cardinal Health 110, Inc. | 17695563-3765-74cb-e063-6294a90a6120 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Target Corporation | 1dff278f-47bc-459a-e063-6394a90a2646 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | TopCo Associates | 19c268a1-7b2e-63c9-e063-6394a90acddc | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid Maximum Strength | TOLNAFTATE | Walgreens Company | 137eabb7-cb4f-1631-e063-6294a90ab847 | 2025-08-07 | Warnings | M005 |
| WCTNGO Fungal Nail Treatment Swabs | TOLNAFTATE,UNDECYLENIC ACID | Shenzhen Boyimei Technology Co., Ltd. | 3bad0d73-b33d-b962-e063-6294a90a7ba7 | 2025-08-06 | Warnings | M005 |
| ONIADBA Nail Fungus Treatment Pen | TOLNAFTATE,UNDECYLENIC ACID | Shenzhen Boyimei Technology Co., Ltd. | 3bad19f1-d5b3-c5de-e063-6294a90a0c03 | 2025-08-06 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Premier Brands of America Inc | 2644ba07-aaee-6402-e063-6394a90a2827 | 2025-08-06 | Warnings | M005 |
| Anti- Fungal Miconazole Nitrate | MICONAZOLE NITRATE | Premier Brands of America Inc. | f186bdc1-db6c-0fab-e053-2995a90a7c58 | 2025-08-06 | Warnings | M005 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 309367 | clotrimazole 1 % Topical Cream | PSN | e673748f-d00b-4ce8-e053-2995a90a9220 | 2 |
| 309367 | clotrimazole 10 MG/ML Topical Cream | SCD | e673748f-d00b-4ce8-e053-2995a90a9220 | 2 |
| 309367 | clotrimazole 1 % Topical Cream | SY | e673748f-d00b-4ce8-e053-2995a90a9220 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69771-032-23 | 69771003223 | 113 g in 1 TUBE (69771-032-23) | 113 g | 2022-08-17 | 0000-00-00 | No | No | Current |